Lysophosphatidic acid levels in cerebrospinal fluid and plasma samples in patients with major depressive disorder.

Gotoh, Leo; Yamada, Misa; Hattori, Kotaro; Sasayama, Daimei; Noda, Takamasa; Yoshida, Sumiko; Kunugi, Hiroshi; Yamada, Mitsuhiko.

Afiliação

Gotoh L; Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8553, Japan.
Yamada M; Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8553, Japan.
Hattori K; Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, 187-8502, Japan.
Sasayama D; Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, 187-8551, Japan.
Noda T; Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, 187-8502, Japan.
Yoshida S; Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, Japan.
Kunugi H; National Center of Neurology and Psychiatry Hospital, Tokyo, 187-8551, Japan.
Yamada M; National Center of Neurology and Psychiatry Hospital, Tokyo, 187-8551, Japan.

Heliyon ; 5(5): e01699, 2019 May.

Article em En | MEDLINE | ID: mdl-31193411